Trade MSLE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Satellos Bioscience Inc. (MSLE) is trading at US$9.32, down 3.03% today as of Aug 28, 12:14 EDT. The company has a market capitalisation of US$212.38M. Over the past 52 weeks, MSLE has traded between US$5.44 and US$13.39. On Syfe you can trade MSLE with $0 commission and add it to your watchlist.
| Previous close | US$9.61 |
|---|---|
| Market cap | US$212.38M |
| 52-week range | US$5.44 – US$13.39 |
| Volume | 8.65K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Satellos Bioscience Inc.
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
Year: 2021
Satellos Says Interim Phase 2 Data Shows SAT-3247 Improves Muscle Measures in Adult DMD Patients
Jul 8, 12:29 PM · MT Newswires
Satellos Bioscience' SAT-3247 Secures US FDA Fast Track Status in Duchenne Muscular Dystrophy
Jun 29, 12:03 PM · MT Newswires
--Guggenheim Initiates Satellos Bioscience at Buy With CA$31.43 Price Target
Apr 28, 11:38 AM · MT Newswires
--Leerink Partners Initiates Satellos Bioscience at Outperform
Apr 6, 11:50 AM · MT Newswires
Satellos Bioscience Inc. (MSLE) stock is trading at US$9.32, -3.03% from the previous close of US$9.61.
The market cap for Satellos Bioscience Inc. (MSLE) stock is approximately US$212.38M.
The 52-week high for Satellos Bioscience Inc. (MSLE) stock is US$13.39.
The 52-week low for Satellos Bioscience Inc. (MSLE) stock is US$5.44.
Satellos Bioscience Inc. (MSLE) does not currently pay a dividend.
Stay on top of MSLE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
